RBR-59447vn进行中（未招募）2 期
Effects of the administration of AP1189, a pro resolutive pathways up regulator, on lung alterations of COVID-19 patients and impaired oxygenation
niversidade Federal de Minas Gerais0 个研究点开始时间: 2021年5月29日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 85Y（—）
入选标准
- •Male and female subjects, 18 to 85 years of age hospitalized with COVID-19 infection; Written informed consent; Confirmed COVID-19 by the presence of SARS-CoV-2 nucleic acid by polimerase chain reaction; Pregnancy is excluded or unlikely (reliable contraception/post-menopausal women).
排除标准
- •Progress to death is imminent and unavoidable in the opinion of the investigator; Participating in other clinical trials (except in COVID-19 antiviral drug trials); Any condition that in the view of the screening physician suggests that the patient is unable to comply with study procedures; Subjects treated with immunosuppressive drugs; HIV infection; Pregnant women or breastfeeding mothers; Estimated glomerular filtration rate less than 30ml/min; Severe liver disfunction (Child-Pugh score C); Medical history of oral glucocorticoid treatment (Exception is COVID-19 dexamethasone treatment not exceeding 10mg/day).
研究者
相似试验
进行中（未招募）
不适用
Eficacia y seguridad de AP 12009 en pacientes adultos con astrocitoma anaplásico (grado III de la OMS) recurrente o refractario en comparación con el tratamiento estándar con Temozolomida o BCNU: Estudio clínico fase III aleatorizado, de control activo y etiqueta abierta.Efficacy and Safety of AP 12009 in Adult Patients with Recurrent or Refractory Anaplastic Astrocytoma (WHO grade III) as Compared to Standard Treatment with Temozolomide or BCNU: A Randomized, Actively Controlled, Open Label Clinical Phase III Study. - SAPPHIRERecurrent or Refractory Anaplastic AstrocytomaAstrocitoma anaplásico recurrente o refractarioMedDRA version: 9.1Level: LLTClassification code 10002224Term: Anaplastic astrocytomaEUCTR2007-005802-38-ESAntisense Pharma GmbH132
已完成
不适用
Assessment of the effect of administration of propolis and curry leaf into periodontal pockets on oral microbiotaChronic periodontitisJPRN-UMIN000013850ational Institute of Infectious Diseases24
进行中（未招募）
不适用
EFECTO DE LA ADMINISTRACIÓN DE ALBÚMINA INTRAVENOSA Y MIDODRINA ORAL SOBRE LA FUNCIÓN RENAL DE LOS PACIENTES CON CIRROSIS HEPÁTICA Y INSUFICIENCIA RENAL FUNCIONAL - MAFRIEUCTR2009-011437-27-ESFundació Clínic
进行中（未招募）
1 期
EFECTO DE LA ADMINISTRACIÓN PROLONGADA DE ALBÚMINA Y MIDODRINA EN LA PREVENCIÓN DE COMPLICACIONES EN PACIENTES EN LISTA DE ESPERA DE TRASPLANTE HEPÁTICOMidodrine and Albumin for CirrHotic patients in the waiting list for liverTransplantation - Midrodrine and albumin for cirrhotic patients in the waiting list for liver transplantatioPacientes afectos de cirrósis hepática en lista de espera para trasplante HepáticoMedDRA version: 9.1Level: LLTClassification code 10019641Term: Hepatic cirrhosisEUCTR2007-005723-14-ESFundació Clinic per a la recerca biomèdica
进行中（未招募）
不适用
EFECTOS DE LA ADMINISTRACIÓN DE ALBÚMINA INTRAVENOSA SOBRE LA FUNCIÓN DIASTÓLICA DE LOS PACIENTES CON CIRROSIS HEPÁTICA.EUCTR2005-005083-81-ESHOSPITAL CLINIC